Please assess the completion status of the following clinical trial:

Trial Title: Misoprostol for Reduction of Blood Loss During Fibroid Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients presenting for abdominal myomectomy with documented uterine fibroids on pelvic imaging (pelvic ultrasound or MRI) within in last 12 months~* Age ≥ 18 years and ≤ 50 years~* Pre-operative hemoglobin \>8 g/dl~* Willing to have buccal administration of misoprostol or a placebo at least one hour pre-procedure.~* Ability to understand and the willingness to sign a written informed consent.~* Admissible medical/surgical history~* Can be previously treated with Depo-Lupron, Depo-Provera, or Oral Contraceptive pills~* Intraoperative use of vasopressin and uterine tourniquet is permissible~* Can have had prior Cesarean delivery~Exclusion Criteria:~* Patients who have had a prior abdominal myomectomy~* Post-menopausal women~* Patients with known bleeding/clotting disorders~* Patients with a history of gynecologic malignancy~* History of allergic reactions attributed to compounds of similar chemical or biologic composition to misoprostol~* Any cases converted to abdominal hysterectomy or other additional elective surgical procedures performed at time of abdominal myomectomy will be excluded from data analysis~* Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: t

Study Arms:
- Misoprostol (Type: EXPERIMENTAL): 25 patients undergoing abdominal myomectomy operation will receive two tablets of misoprostol (400 mcg) buccally one hour before the operation.
- Placebo (Type: PLACEBO_COMPARATOR): 25 patients undergoing abdominal myomectomy operation will receive two tablets of Vitamin B6 (100mg) buccally one hour before the operation.

Based on this trial design, predict the completion outcome and termination type (if applicable).